Analysis reportAll specifications met
Retatrutide 30mg
Peptide Stock ref. PSV-2609-RT30-02
Purity99.73%HPLC-UV
Content per vial33.13 mg110.4% of 30 mg label claim
IdentityConfirmedLC-MS
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (LC-MS) | Retatrutide | Confirmed | Pass |
| Purity (HPLC-UV) | — | 99.73% | Reported |
| Net content | — | 33.13 mg (110.4% of claim) | Reported |
About this report
- Sample received by the lab 25 September 2026; report issued 27 September 2026.
- Appearance as received: white lyophilised powder.
- Results relate to the sample tested. For laboratory research use only.